SCHEMBL16050559

SCHEMBL16050559

Cc1[nH]c2c(C#N)cnn2c(=O)c1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLAT P00750 3/20 0.42
▸ KDM5A P29375 4/20 0.40
▸ KDM4D Q6B0I6 1/20 0.40
▸ ATM Q13315 1/20 0.37
▸ KDM4E B2RXH2 7/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ GAA P10253 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ MDM2 Q00987 1/20 0.33
▸ HPGD P15428 4/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ KDM4C Q9H3R0 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ PDE5A O76074 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16046987 0.80 KDM5A (0.56) PLATKDM5AKDM4DKDM4EALDH1A1
SCHEMBL16047831 0.80 KDM5A (0.45) PLATKDM5AKDM4DKDM4C
SCHEMBL16046669 0.78 KDM5A (0.48) PLATKDM5AKDM4DKDM4EALDH1A1
SCHEMBL16046338 0.78 PLAT (0.50) PLATKDM5AKDM4DKDM4EALDH1A1
SCHEMBL16092479 0.77 MDM2 (0.52) PLATKDM5AKDM4DKDM4EALDH1A1
SCHEMBL16050574 0.77 KDM5A (0.42) PLATKDM5AKDM4DKDM4EALDH1A1
SCHEMBL9204181 0.77 KDM4E (0.45) PLATKDM5AKDM4DKDM4EALDH1A1
SCHEMBL16046333 0.77 KDM5A (0.45) PLATKDM5AKDM4DKDM4EALDH1A1
SCHEMBL16046173 0.77 KDM5A (0.44) PLATKDM5AKDM4DKDM4EALDH1A1
SCHEMBL17547885 0.76 KDM5A (0.40) PLATKDM5AKDM4DKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970307-B1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH INC (US) 2020-03-11 — — EP disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
EP-2970307-A1 PYRAZOLO COMPOUNDS AND USES THEREOF Genentech, Inc. (US) 2016-01-20 — — EP disclosed
WO-2015135094-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2015-09-17 — — WO disclosed
WO-2014139326-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B PLAT 4107/4885KDM5A 1/4885KDM4D 18/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B PLAT 4107/4885KDM5A 1/4885KDM4D 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback